|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.054 HKD | -8.47% |
|
+35.00% | +8.00% |
| 25/03 | New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 18/03 | New Ray Medicine International Forecasts Decline in 2023 Loss | MT |
New Ray Medicine International Holding Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 59.29 million compared to HKD 214.49 million a year ago. Net loss was HKD 21.38 million compared to net income of HKD 1.13 million a year ago.
Basic loss per share from continuing operations was HKD 0.0128 compared to basic earnings per share from continuing operations of HKD 0.0007 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.00% | 1.16Cr | |
| -31.23% | 1.58TCr | |
| -22.89% | 1.23TCr | |
| -24.53% | 658.71Cr | |
| +12.51% | 644.7Cr | |
| -12.43% | 593.82Cr | |
| -0.15% | 465.86Cr | |
| +62.00% | 459.2Cr | |
| -5.94% | 395.9Cr | |
| -8.76% | 355.39Cr |
NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED 
